Open Labeled, Randomized, Switch-Over Study of Two Fixed Doses (10/15mg) Of Aripiprazole : To Evaluate its Safety And Efficacy in the Treatment of Indian Patients of Schizophrenia.

Aripiprazole is a new anti psychotic with a unique receptor binding profile that combines partial agonistic activity at D2 receptor and 5-HT 1A receptor and potent antagonism at 5-HT 2A receptor. This receptor profile makes it possible for it to act as a dopamine system stabilizer. Based on various...

Descripción completa

Detalles Bibliográficos
Autores principales: Sarin, A, Nagpal, J, Bohra, N K, Jiloha, R C, Rao, G P, Sharma, S K, Vaishnav, M, Vaya, L, Karan, R S, Patel, N K, Patel, R
Formato: Texto
Lenguaje:English
Publicado: Medknow Publications 2004
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912679/
https://www.ncbi.nlm.nih.gov/pubmed/21206777

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2912679/
https://www.ncbi.nlm.nih.gov/pubmed/21206777

Ejemplares similares